Novo Nordisk (Ozempic)
Acquired
Unique Corporate Structure of Novo Nordisk
Novo Nordisk has a unique corporate structure with an operating company 100% owned and controlled by a foundation. This governance structure greatly impacts the company's incentives, product development, and market approach. This structure is common in Danish companies due to tax reasons and serves as a generational transfer mechanism. The Nordisk Foundation has a dual mission of selling insulin at cost in Scandinavia for public health benefit, while exporting at market prices to fund further diabetes research and development, with all profits being used for grants and research in Scandinavia.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
